Transdigm Group INC Form 4 insider transactions

TransDigm Group's President and CEO, Kevin M. Stein, exercised stock options and sold shares on March 12, 2025, according to a recent SEC Form 4 filing.

Director Robert Small reports the sale of TransDigm Group INC shares held indirectly through Stockbridge Partners LLC and Stockbridge Fund, L.P.

Director Robert Small reports the sale of TransDigm Group INC shares held indirectly through Stockbridge Partners LLC and Stockbridge Fund, L.P.

Jessica L. Warren, GC, CCO, and Secretary of TransDigm Group INC, exercised stock options and sold shares of common stock on March 4, 2025.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, reports the exercise of stock options and subsequent sale of common stock on February 20, 2025.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on February 18, 2025, according to a Form 4 filing with the SEC.

Director Robert J. Small exercised stock options and sold shares of TransDigm Group INC on February 14, 2025.

CEO Kevin Stein exercised stock options and sold shares of TransDigm Group INC on February 12, 2025, according to a recent SEC Form 4 filing.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold shares on January 21, 2025, according to a recent SEC filing.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on January 15, 2025, according to a recent SEC filing.

TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares on January 13, 2025, according to a recent SEC filing.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on December 20, 2024, according to a Form 4 filing with the SEC.

TransDigm Group INC director W. Nicholas Howley exercised stock options and sold shares held indirectly through a family trust on December 16, 2024.

TransDigm Group's CEO, Kevin M. Stein, exercised stock options and sold a significant number of shares held in a trust on December 12, 2024.

Director Robert J. Small of TransDigm Group INC sold a total of 38,053 shares of common stock across multiple transactions on December 12, 2024.

Director Michael Graff of TransDigm Group INC reported the disposal of 200 common stock shares, alongside holdings through his wife and trusts.

TransDigm Group director Gary E. McCullough acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

TransDigm Group director Sean P. Hennessy acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Robert J. Small, a director at TransDigm Group, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Michele Santana, a director at TransDigm Group, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Director Jorge L. Valladares III acquired 450 stock options in TransDigm Group INC on October 31, 2024.

A TransDigm Group director, David Barr, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Director Jane M. Cronin acquired 450 stock options in TransDigm Group, exercisable starting September 30, 2025, based on performance targets.

A TransDigm Group director, Michael Graff, acquired 450 stock options on October 31, 2024, which vest based on future performance targets.

Jessica L. Warren, General Counsel, Chief Compliance Officer, and Secretary of TransDigm Group, acquired 7,900 stock options on October 31, 2024.

TransDigm Group's Chief Financial Officer, Sarah Wynne, acquired 8,200 stock options on October 31, 2024, which vest based on future performance targets.

Michael Lisman, Co-Chief Operating Officer of TransDigm Group, acquired 9,850 stock options on October 31, 2024.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold a portion of his holdings on November 20, 2024.

TransDigm Group's CEO, Kevin M. Stein, acquired 38,900 stock options on October 31, 2024, which vest based on the company's fiscal 2029 performance.

TransDigm Group director W. Nicholas Howley exercised stock options and sold a portion of his holdings on November 15, 2024.